Veterinary and Comparative Oncology

Papers
(The median citation count of Veterinary and Comparative Oncology is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
Serum thymidine kinase 1 activity as a prognostic biomarker in dogs with chemotherapy‐treated diffuse large B‐cell lymphoma22
Ultrasound‐guided core needle biopsy in dogs with thyroid carcinoma21
Investigation of efficacy of two different chemotherapy protocols used in neoadjuvant chemotherapy in clinical stages II–IV canine malignant mammary tumours19
Effects of a high‐protein, increased‐fibre, dry diet supplemented with omega‐3 fatty acids on quality of life in dogs undergoing chemotherapy19
Outcomes of 35 dogs with craniomaxillofacial osteosarcoma treated with stereotactic body radiation therapy19
Treatment of feline intermediate to high‐grade alimentary lymphoma: A retrospective evaluation of 55 cats treated with the VAPC combination chemotherapy protocol (2017–2021)17
Issue Information16
Timely adjuvant chemotherapy improves outcome in dogs with non‐metastatic splenic hemangiosarcoma undergoing splenectomy16
High lysyl oxidase expression is an indicator of poor prognosis in dogs with cutaneous mast cell tumours15
Descriptive analysis of haemangiosarcoma occurrence in dogs enrolled in the Golden Retriever lifetime study15
Blood biomarkers for canine cancer, from human to veterinary oncology13
Pre‐operative neoadjuvant vinblastine‐prednisolone in canine mast cell tumours: A single‐centre retrospective cohort study13
Outcome of dogs treated with chemotherapy for mesothelioma: A retrospective clinical study on 40 cases and a literature review13
Standardisation of canine meningioma grading: Inter‐observer agreement and recommendations for reproducible histopathologic criteria13
Plasma cell‐free DNA in canine lymphoma patients as a novel material for genotyping12
Combining radiation therapy with zoledronate for the treatment of osteo‐invasive feline oral squamous cell carcinoma12
Dysregulated miRNAs in a canine model of haemangiosarcoma metastatic to the brain12
Risk factors associated with the onset of lomustine‐induced neutropenia in tumour‐bearing dogs11
Issue Information11
11
Polarisation Sensitive Optical Coherence Tomography Image Characteristics for Gastrointestinal Tumours and Normal Tissues at Surgical Margins in Dogs11
Corrigendum11
Cover Image10
9
Issue Information9
Issue Information9
Author Index9
Chronic adrenergic stress and generation of myeloid‐derived suppressor cells: Implications for cancer immunotherapy in dogs9
Expression of Concern: Tumour necrosis factor‐alpha‐induced protein 8 (TNFAIP8) expression associated with cell survival and death in cancer cell lines infected with canine distemper virus8
Immunophenotyping and Mutation Analysis of Canine Intestinal T‐Cell Lymphoma: A Comparative Pathological Study of Human Enteropathy‐Associated T‐Cell Lymphoma8
Extensive staging has no prognostic value in dogs with low‐risk mast cell tumours8
Classification and Prognostication of B‐Cell and T‐Cell Multicentric Lymphoma in Dogs Using Serum MicroRNAs8
Effects of Lipophilic Statins on Cell Viability and Tissue Factor Expression in Canine Haemangiosarcoma Cells8
8
Fractionated oral dosing and its effect on cyclophosphamide pharmacokinetics in dogs with high‐grade multicentric lymphoma8
8
Efficacy and toxicity of carboplatin in the treatment of macroscopic mesenchymal neoplasia in dogs8
Use of Cystourethroscopy to Define the Gross Tumour Volume in Radiation Treatment Planning for Canine Genitourinary Carcinomas8
Spotlight on capecitabine for the treatment of unresectable or metastatic carcinoma of various origin: A retrospective study of 25 dogs8
Issue Information7
Author Index7
7
Issue Information7
Epidemiology of canine cutaneous round cell tumours on the canary archipelago in Spain7
Frontal sinus carcinoma in forty‐one dogs (2001–2022)7
6
Blood Neutrophil‐to‐Lymphocyte Ratio as a Potential Prognostic Marker in Dogs ≤10 kg With Multicentric Lymphoma6
Issue Information6
Prognostic impact of bone invasion in canine oral malignant melanoma treated by surgery and anti‐CSPG4 vaccination: A retrospective study on 68 cases (2010–2020)6
Issue Information6
6
DNA Methylation and Its Effects on TRIM29 Gene Expression in the Equine Sarcoid Tissue6
Comparison of the anticancer effects of various statins on canine oral melanoma cells5
Outcome in dogs with curative‐intent treatment of localized primary pulmonary histiocytic sarcoma5
Quantification of circulating tumour cells over time in dogs with appendicular osteosarcoma5
Retrospective analysis of outcome and prognostic factors of subcutaneous mast cell tumours in dogs undergoing surgery with or without adjuvant treatment5
Evaluation of serum interleukin 2 receptor and beta‐2‐microglobulin as prognostic factors for canine lymphoma: A pilot study5
Impact of 10% Dose Reductions and Duration of Treatment Delays in the Management of Chemotherapy‐Induced Neutropenia in Dogs Treated With Common Chemotherapy Protocols: A Single‐Centre Experience5
Use of Lomustine and Prednisolone as First‐Line Treatment in Canine Multicentric Lymphoma5
Defining the relevance of surgical margins. Part two: Strategies to improve prediction of recurrence risk5
Evaluation of the health‐related quality of life in dogs following intracranial meningioma resection using a specifically developed questionnaire5
5
Sodium iodide symporter immunolabelling as a predictor of clinical iodide uptake in canine thyroid carcinoma: A preliminary study5
Serum Lactate Dehydrogenase as a Potential Prognostic Biomarker in Dogs With Appendicular Osteosarcoma5
Configuration of pathologic fractures in dogs with osteosarcoma following stereotactic body radiation therapy: A retrospective analysis5
Overactivation of Signal Transducer and Activator of Transcription 3 in Canine Hepatocellular Carcinoma and Its Prognostic Significance5
Identification of potential plasma protein biomarkers for feline pancreatic carcinoma by liquid chromatography tandem mass spectrometry5
Isolation of Tumour‐Derived Extracellular Vesicles From the Plasma of Dogs Affected by Intracranial Tumours Showing Heterologous and Cross‐Species Tropism: A Pilot Study5
4
Description and efficacy of a response‐based “QUAD” cyclical hypofractionated palliative‐intent radiation protocol in dogs with macroscopic solid tumours: 108 cases4
Vinorelbine as a Rescue Treatment for Canine Histiocytic Sarcoma: A Multicentre Retrospective Study of 18 Dogs4
Stereotactic body radiation therapy as an alternative to adrenalectomy for the treatment of pheochromocytomas in 8 dogs4
Mass spectrometric‐based assessment of the serum kappa to lambda immunoglobulin light chain ratio (κ:λ) in dogs with immunoglobulin secretory diseases4
VCS abstract4
Outcome with surgical treatment of canine soft tissue sarcoma in the region of the ischiatic tuberosity: A veterinary society of surgical oncology retrospective study4
Clinical outcomes in cats with renal carcinoma undergoing nephrectomy: A retrospective study4
Cyclical 10‐day dosing of melphalan for canine multiple myeloma4
Developing a translational murine‐to‐canine pathway for anIL‐2/agonistanti‐CD40antibody cancer immunotherapy4
The role of toceranib phosphate in dogs with non‐mast cell neoplasia: A systematic review4
Evaluation of the anti‐tumour activity of Coriolus versicolor polysaccharopeptide (I'm‐Yunity) alone or in combination with doxorubicin for canine splenic hemangiosarcoma4
Molecular Classification Based on the Gene Expression Profiles in Canine Histiocytic Sarcoma Cells4
Half‐Body Radiation Therapy Results in a Prolonged Progression‐Free Interval in Canine High‐Grade Lymphoma After First Remission4
A retrospective study of 101 dogs with oral melanoma treated with a weekly or biweekly 6 Gy × 6 radiotherapy protocol4
Correction to “DNA Methylation and Its Effects on TRIM29 Gene Expression in the Equine Sarcoid Tissue”4
Immunological Pre‐Metastatic Niche in Dogs With Naturally Occurring Osteosarcoma4
Sentinel lymph node mapping in canine mast cell tumours using a preoperative radiographic indirect lymphography: Technique description and results in 138 cases4
Ovariectomy reduces the risk of tumour development and influences the histologic continuum in canine mammary tumours4
4
Correlation between computed tomography and histological evaluation of nodal metastasis in dogs with mast cell tumours4
Evaluating the relevance of surgical margins. Part one: The problems with current methodology4
Sentinel lymph node mapping with computed tomography lymphography for mast cell tumours and a comparison between regional and sentinel lymph node histological status: Sixty‐two cases4
Flow Cytometry for the Detection and Quantification of Mast Cells in Lymph Nodes: A Prospective Study in 64 Dogs With Mast Cell Tumour3
3
Comprehensive Analysis of the Tumour Immune Microenvironment in Canine Urothelial Carcinoma Reveals Immunosuppressive Mechanisms Induced by the COX–Prostanoid Cascade3
Prognostic Impact of a Histologic Grading Scheme in Dogs Diagnosed With Rib Chondrosarcoma3
Newcastle disease virus LaSota strain induces apoptosis and activates the TNFα/NF‐κB pathway in canine mammary carcinoma cells3
A retrospective study of canine oral extramedullary plasmacytoma over a 15‐year period (July 2004–July 2019): Treatment, histologic parameters and clinical outcomes3
Characterisation of Gene Expression in Canine Invasive Urothelial Carcinoma Using a NanoString‐Based Urine Assay3
Thromboelastographic results and hypercoagulability in dogs with surgically treated hepatocellular adenoma and carcinoma: A Veterinary Society of Surgical Oncology prospective study3
Correction to: Standardization of canine meningioma grading: Validation of new guidelines for reproducible histopathologic criteria3
Hotspot Exon 15 Mutations in BRAF Are Uncommon in Feline Tumours3
The animal's microbiome and cancer: A translational perspective3
Prognostic significance of CD25 expression in dogs with a noninvasive diagnosis of B‐cell lymphoma treated with CHOP chemotherapy3
Early‐Delayed Radiotoxicity Associated With Stereotactic Radiation Therapy Following a Daily 6 Gy × 5 (30 Gy) Protocol for Presumed Canine Intracranial Meningiomas3
Shear wave elastography of lymph nodes in dogs with head and neck cancer: A pilot study3
One Health: Therapies Targeting Genetic Variants in Human and Canine Histiocytic and Dendritic Cell Sarcomas3
VCS 2024 Abstracts3
Establishment and characterisation of cell lines and xenograft mouse models of canine systemic histiocytosis and disseminated histiocytic sarcoma3
Evaluation of mechlorethamine, vinblastine, procarbazine, and prednisone for the treatment of resistant multicentric canine lymphoma3
Are severe adverse events commonly observed in dogs during cancer chemotherapy? A retrospective study on 155 dogs3
Issue Information3
Axillary lymphadenectomy in dogs: A description of surgical technique3
Serum level of apoptosis inhibitor of macrophage in dogs with histiocytic sarcoma and its association with the disease3
Clinical Utility of Circulating Cell‐Free DNA as a Liquid Biopsy in Cats With Various Tumours2
Canine anal sac gland carcinoma with regional lymph node metastases treated with sacculectomy and lymphadenectomy: Outcome and possible prognostic factors2
Outcome of dogs with bone marrow suppression secondary to Sertoli cell tumour2
Impacts of Vincristine and Prednisolone Chemotherapy on the Canine Gut Microbiota in Dogs Undergoing Treatment for Lymphoma2
Effect of Changes in Canine Thyroid Cancer Terminology on Caregiver Anxiety Levels and Treatment Preferences in a Scenario‐Based Study2
Issue Information2
Lifetime prevalence of malignant and benign tumours in companion dogs: Cross‐sectional analysis of Dog Aging Project baseline survey2
CDC6: A novel canine tumour biomarker detected in circulating extracellular vesicles2
Expression of the hedgehog signalling pathway and the effect of inhibition at the level of smoothened in canine osteosarcoma cell lines2
Do Pre‐Treatment Biopsy Characteristics Predict Early Tumour Progression in Feline Diffuse Large B Cell Nasal Lymphoma Treated With Radiotherapy?2
Inhibitory checkpoint molecule mRNA expression in canine soft tissue sarcoma2
Comparison of Three Chemotherapy Protocols With Electrochemotherapy for the Treatment of Feline Cutaneous Squamous Cell Carcinoma2
Safety and feasibility of short course pre‐operative radiation therapy followed by surgical excision for canine solid tumours2
Sequence Diversity and Expression Profiles of T Cell Receptor Beta Chain Constant Genes TRBC1 and TRBC2 in Canine Lymphoid Tumour Cell Lines and Normal Lymphocytes2
Prognostic Impact of Mast Cell Infiltration Detected by Flow Cytometry on Excised Sentinel Lymph Nodes in Dogs With Newly Diagnosed Mast Cell Tumours2
Surgical and oncologic outcomes in dogs with malignant peripheral nerve sheath tumours arising from the brachial or lumbosacral plexus2
Long‐term survival of dogs with stage 4 oral malignant melanoma treated with anti‐canine PD‐1 therapeutic antibody: A follow‐up case report2
Author Index2
Diagnostic accuracy of optical coherence tomography for surgical margin assessment of feline injection‐site sarcoma2
Issue Information2
Toosendanin‐induced apoptosis of CMT‐U27 is mediated through the mitochondrial apoptotic pathway2
Retrospective study evaluating the efficacy of stereotactic body radiation therapy for the treatment of confirmed or suspected primary pulmonary carcinomas in dogs2
2
Outcome and Prognostic Factors of Dogs Treated for Infiltrative Lipoma Undergoing Radiation Therapy: A Retrospective Multi‐Institutional Study of 29 Cases2
Immunohistochemical and transcriptomic characterization of T and myeloid cell infiltrates in canine malignant melanoma2
A multi‐institutional epidemiologic study evaluating environmental risk factors for feline oral squamous cell carcinoma2
Evaluation of the therapeutic potential of masitinib and expression of its specific targets c‐Kit, PDGFR‐α, PDGFR‐β, and Lyn in canine prostate cancer cell lines2
Neurological Recovery in 14 Cats With Epidural Lymphoma Treated With Chemotherapy2
Cover Image2
Risk factors influencing death prior to discharge in 302 dogs undergoing unilateral adrenalectomy for treatment of primary adrenal gland tumours2
Issue Information2
Prognostic indicators for naïve canine non‐indolent T‐cell lymphoma treated with combination lomustine, vincristine, procarbazine and prednisolone chemotherapy2
Vincristine Induced Adverse Effects in Lymphoma Bearing Dogs With Asymptomatic Neutropenia at the Time of Drug Administration2
Evaluation of the Amount of Compounded Chemotherapy Drugs: A Comparison Between Nine Compounding Pharmacies2
Precision in Parsing: Evaluation of an Open‐Source Named Entity Recognizer (NER) in Veterinary Oncology2
BRAF mutation status and its prognostic significance in 79 canine urothelial carcinomas: A retrospective study (2006–2019)2
Patterns of nodal metastases, biological behaviour and prognosis of canine mast cell tumours of the pinna: A multi‐institutional retrospective study1
Preoperative Computed Tomography Features as Predictors of Malignancy and Survival in Canine Adrenal Tumours1
Investigation of a 4.3 Gy × 10‐Fraction Volumetric Modulated Arc Therapy Protocol for Canine Prostatic Carcinoma: A Normal Tissue Complication Probability Study1
Issue Information1
Impact of palliative‐intent radiotherapy with or without chemotherapy on lameness in flat coat retrievers with localised periarticular histiocytic sarcoma – a retrospective cohort, single institution 1
Tumour necrosis factor stimulated gene 6 intrinsically regulates PD‐L1 expressions in breast cancer cells, leading to modulation of tumour microenvironment1
Evaluating the Impact of Elective Nodal Irradiation for Dogs With Oral Malignant Melanoma Undergoing Hypofractionated Radiotherapy1
Establishment of a new cell line of canine inflammatory mammary cancer: IMC‐1181
Allogeneic peripheral blood haematopoietic stem cell transplantation for the treatment of dogs with high‐grade B‐cell lymphoma1
Chemoresistance Cytological Score for Canine Transmissible Venereal Tumour: A Proposed System of Predicting Vincristine Resistance1
Conventional fractionated radiotherapy outcomes for young dogs with nephroblastoma of the spinal cord: 5 cases1
Comparative gene expression study highlights molecular similarities between triple negative breast cancer tumours and feline mammary carcinomas1
Editorial1
Patterns of metastatic progression and association with clinical outcomes in canine osteosarcoma: A necropsy study of 83 dogs1
An aggressive CD4CD8 T‐cell neoplasm in young English bulldogs1
Abstracts1
Molecular differences in mitochondrial DNA genomes of dogs with malignant mammary tumours1
Editorial1
Response of canine thyroid carcinomas to radioiodine1
Issue Information1
Calculation of dose intensity and comparison of published methods using a cohort of canine T‐cell lymphoma patients undergoing CHOP‐based chemotherapy1
Genomic Evaluation of Canine Prostatic Carcinomas as a Model for the Human Disease: or ‘UC or not UC – that is the question’1
Standardization of canine meningioma grading: Validation of new guidelines for reproducible histopathologic criteria1
Pilot study to evaluate isolation by size of circulating tumour cells in canine oral melanoma1
The expression of histone lysine demethylase 2B in canine hemangiosarcoma is associated with disease progression1
Immunohistochemical Expression of Programmed Death‐Ligand 1 and Cytotoxic T‐Lymphocyte Antigen‐4 in Canine Cutaneous Mast Cell Tumours1
Feline primary nonhematopoietic malignant liver tumours: A multicenter retrospective study (2000–2021)1
Multi‐institutional retrospective study of canine foot pad malignant melanomas: 20 cases1
New molecular targets in canine hemangiosarcoma—Comparative review and future of the precision medicine1
1
Molecular and Pathobiology of Canine Mammary Tumour: Defining a Translational Model for Human Breast Cancer1
Evaluation of Decreased Kidney Function in Dogs Receiving Carboplatin: A Retrospective Cohort Study of 98 Dogs (2006–2024)1
1
Urinary and household chemical exposures in pet dogs with urothelial cell carcinoma1
Evaluation of lymphocyte‐specific programmed cell death protein 1 receptor expression and cytokines in blood and urine in canine urothelial carcinoma patients1
Tolerability Assessment of Orally Administered Paclitaxel With Encequidar in Dogs With Spontaneous Malignancy1
1
Transferrin Receptor‐1: Expression in Canine Mammary Tumours and In Vitro Therapeutic Applications1
Macrophage Colony Stimulating Factor (M‐CSF) and Interleukin‐34 (IL‐34) Expression in Canine Osteosarcoma in the Context of the Tumour Immune Microenvironment1
1
The association between symmetric dimethylarginine concentrations and various neoplasms in dogs and cats1
Issue Information1
Issue Information1
Visualizing the cancer stem‐like properties of canine tumour cells with low proteasome activity1
Re‐irradiation of canine non‐lymphomatous nasal tumours using stereotactic radiation therapy (10 Gy x 3) for both courses: Assessment of outcome and toxicity in 11 dogs1
1
0.062520980834961